Pharma IQ Members


Colleen McGraw
Colleen currently serves as the Director of Labelling at Vertex Pharmaceuticals in Cambridge, MA where she brings over 15 years of experience in labelling. Her most recent labeling successes include the approval and launch of IncivekTM (telaprevir) for hepatitis C in the US and KalydecoTM (ivacaftor) for cystic fibrosis in the US and Europe.
Prior to Vertex, Colleen headed Labelling departments at Stiefel Laboratories in Research Triangle Park, NC; TAP Pharmaceuticals in Lake Forest, IL; and Alcon Laboratories in Fort Worth, TX.